1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester CAS:503614-91-3

The chemical structure of 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester imparts unique properties that make it a valuable candidate for pharmaceutical applications. Its fusion of pyrazole, pyridine, and piperidine rings offers a platform for designing novel drug candidates or pharmacophores with diverse biological activities. In medicinal chemistry, researchers exploit the multifunctional nature of this compound to develop potent and selective drug molecules targeting specific biological pathways or disease mechanisms. The presence of the oxo group, ester moiety, and various aromatic rings in the molecule's structure provides opportunities for molecular modifications and structure-activity relationship studies to optimize its pharmacological profile. The piperidine ring and pyrazolo-pyridine core of 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester offer potential interactions with biological targets such as enzymes, receptors, or ion channels. By designing analogs or derivatives based on this scaffold, scientists can explore new therapeutic avenues for treating a range of medical conditions, including neurological disorders, oncology, and infectious diseases. Moreover, the compound's structural diversity and pharmacological versatility make it a valuable tool in drug discovery programs aimed at identifying lead compounds or drug candidates with enhanced efficacy and improved safety profiles. Through synthetic optimization and biological evaluation, researchers can harness the pharmaceutical potential of 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester to advance the development of innovative medications for unmet medical needs. In conclusion, 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester represents a promising scaffold in medicinal chemistry, offering opportunities for designing and optimizing pharmaceutical agents with diverse pharmacological activities. Its structural complexity and potential therapeutic applications highlight its significance in drug discovery and development efforts to address complex medical challenges and improve patient outcomes.